🇺🇸 Gentamicin Sulfate, Injectable in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Balance Disorder — 2 reports (12.5%)
  2. Cerebellar Syndrome — 2 reports (12.5%)
  3. Deafness Neurosensory — 2 reports (12.5%)
  4. Dizziness — 2 reports (12.5%)
  5. Fall — 2 reports (12.5%)
  6. Vestibular Disorder — 2 reports (12.5%)
  7. Cerumen Impaction — 1 report (6.25%)
  8. Difficulty In Walking — 1 report (6.25%)
  9. Erythema — 1 report (6.25%)
  10. Eye Pain — 1 report (6.25%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Gentamicin Sulfate, Injectable approved in United States?

Gentamicin Sulfate, Injectable does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Gentamicin Sulfate, Injectable in United States?

Public Health Service of Amsterdam is the originator. The local marketing authorisation holder may differ — check the official source linked above.